Levy G A, Edgington T S
J Exp Med. 1980 May 1;151(5):1232-44. doi: 10.1084/jem.151.5.1232.
Murine splenic lymphoid cells have been shown to possess basal procoagulant activity. This activity was localized to most macrophages by assay of cell populations, as well as by a direct plaque assay that permitted identification of expressed procoagulant activity of individual viable cells as well as content. Both content and viable expression of procoagulant activity was markedly increased by exposure to bacterial lipopolysaccharide, reaching a maximum after 6 h. The quantitative increase in procoagulant activity content and viable expression was limited to the macrophage population. Separated populations of lymphocytes or macrophages could not be stimulated by lipopolysaccharide to increase procoagulant activity, whereas the addition of lymphocytes to macrophages at a 3-4:1 ratio maximally reconstituted the amplification of procoagulant activity. Further evidence of cellular collaboration followed from observation that only lymphocytes that had been exposed to lipopolysaccharide were capable of triggering the increase in macrophage procoagulant activity. This appears to represent a new form of lymphocyte-macrophage cooperation in an effector pathway that may participate in some forms of immunologic responses and contribute to the phenotypic features of certain immunologic tissue lesions.
已证实小鼠脾脏淋巴细胞具有基础促凝活性。通过对细胞群体进行检测,以及通过一种直接噬斑测定法(该方法能够鉴定单个活细胞的促凝活性表达及其含量),发现这种活性定位于大多数巨噬细胞。暴露于细菌脂多糖后,促凝活性的含量和活性表达均显著增加,6小时后达到最大值。促凝活性含量和活性表达的定量增加仅限于巨噬细胞群体。分离的淋巴细胞或巨噬细胞群体不能被脂多糖刺激以增加促凝活性,而以3 - 4:1的比例将淋巴细胞添加到巨噬细胞中可最大程度地重建促凝活性的放大。细胞协作的进一步证据来自以下观察结果:只有暴露于脂多糖的淋巴细胞才能触发巨噬细胞促凝活性的增加。这似乎代表了效应途径中淋巴细胞 - 巨噬细胞合作的一种新形式,可能参与某些形式的免疫反应,并促成某些免疫组织病变的表型特征。